CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Camp4 Therapeutics Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$3.14−0.03 (-0.95%)
Close on Oct 19, 2026
- Market cap
- $181.90M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Dividends
Camp4 Therapeutics has not reported a dividend
No dividend per share appears in Camp4 Therapeutics's annual filings since fiscal 2022.